Hematogone hyperplasia - A double edged sword

Retrospection and prospect of Current Cancer Reports (CCR)

“…Mukuku's team reported their series of research results on malignant tumors of Congo local characteristics [9][10][11][12]. Langer et al displayed their critical thinking about hematogone hyperplasia [13] and novel careful observation on Day 21 serum FLC level variation during therapy of symptomatic multiple myeloma [14]. These findings suggest that the current anticancer research is no longer limited to the exploration of the molecular mechanism of carcinogenesis, western medicine surgery, radiotherapy and chemotherapy.…”